Young Joo Lee

In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy

A. Sood, Jeong-Won Lee, Yeong‐Min Park, 2016, Scientific Reports.

Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy

A. Sood, Jeong-Won Lee, Yeong‐Min Park, 2016, International journal of nanomedicine.

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer

A. Sood, Jeong-Won Lee, H. Han, 2018, Drug delivery.

CD44-targeted PLGA nanoparticles incorporating paclitaxel and FAK siRNA overcome chemoresistance in epithelial ovarian cancer

A. Sood, Hyung Jun Ahn, I. Jung, 2018 .

CD 44-targeted PLGA nanoparticles incorporating paclitaxel and FAK siRNA overcome chemoresistance in epithelial ovarian cancer

A. Sood, Han, Jeong-Won Lee, 2018 .

CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.

A. Sood, Y. Cho, H. Han, 2018, Cancer research.